Id |
Subject |
Object |
Predicate |
Lexical cue |
T18 |
0-151 |
Sentence |
denotes |
By alignment of the RBD sequences of SARS-CoV and SARS-CoV-2, we identified the region of SARS-CoV-2 RBD at residues 331 to 524 of S protein (Fig. 1a). |
T19 |
152-453 |
Sentence |
denotes |
We then constructed a recombinant RBD protein containing codon-optimized RBD sequences with a C-terminal Fc of human IgG1 (hFc) using pFUSE-hIgG1-Fc2 expression vector, expressed the protein in mammalian cell 293T, and purified it from cell culture supernatant using protein A affinity chromatography. |
T20 |
454-581 |
Sentence |
denotes |
Similar to SARS-CoV and MERS-CoV RBD protein controls, SARS-CoV-2 RBD protein had high expression with strong purity (Fig. 1b). |
T21 |
582-927 |
Sentence |
denotes |
Notably, only SARS-CoV-2 and SARS-CoV RBDs were recognized by SARS-CoV RBD-specific, but not MERS-CoV RBD-specific, polyclonal antibodies (Fig. 1c), whereas only MERS-CoV RBD was recognized by MERS-CoV RBD-immunized polyclonal antibodies (Fig. 1d), suggesting the cross-reactivity of SARS-CoV RBD-specific antibodies with SARS-CoV-2 RBD protein. |
T22 |
928-1066 |
Sentence |
denotes |
Fig. 1 Characterization of SARS-CoV-2 RBD. a Multiple sequence alignment of RBDs of SARS-CoV-2, SARS-CoV, and MERS-CoV spike (S) proteins. |
T23 |
1067-1177 |
Sentence |
denotes |
GenBank accession numbers are QHR63250.1 (SARS-CoV-2 S), AY278488.2 (SARS-CoV S), and AFS88936.1 (MERS-CoV S). |
T24 |
1178-1354 |
Sentence |
denotes |
Variable amino acid residues between SARS-CoV-2 and SARS-CoV are highlighted in cyan, and conserved residues among SARS-CoV-2, SARS-CoV, and MERS-CoV are highlighted in yellow. |
T25 |
1355-1492 |
Sentence |
denotes |
Asterisks represent fully conserved residues, colons represent highly conserved residues, and periods represent lowly conserved residues. |
T26 |
1493-1541 |
Sentence |
denotes |
The alignment was performed using Clustal Omega. |
T27 |
1542-1606 |
Sentence |
denotes |
SDS-PAGE (b) and Western blot (c, d) analysis of SARS-CoV-2 RBD. |
T28 |
1607-1674 |
Sentence |
denotes |
The protein molecular weight marker (kDa) is indicated on the left. |
T29 |
1675-1728 |
Sentence |
denotes |
SARS-CoV and MERS-CoV RBDs were included as controls. |
T30 |
1729-1855 |
Sentence |
denotes |
Antisera (1:3,000 dilution) from mice immunized with SARS-CoV RBD (c) and MERS-CoV RBD (d) were used for Western blot analysis |